Trial Profile
Safety and Efficacy of sofosbuvir-based regimens in patients with chronic HCV infection and compensated or decompensated cirrhosis: A Gilead Cirrhosis Registry study
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2018
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 05 Jun 2018 Results (As of 5 OCT 2017; n=1564) assessing long-term outcomes in patients with cirrhosis who achieved SVR following treatment with a sofosbuvir based regimen, presented at the Digestive Disease Week 2018
- 16 May 2018 New trial record
- 14 Apr 2018 Results (n=1564; as of 5 OCT 2017) presented at The International Liver Congress 2018.